SEC Form 4/A · accession 0001127602-18-037524
PDS Biotechnology Corp · PDSB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
W Bradford Middlekauff
Officer — Senior VP, GC and Secretary
Period of report
Aug 9, 2016
Accepted (ET)
Dec 31, 2018 · 8:43 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001472091
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 12,851 | I | 401(K) Plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects periodic contributions to the issuer's common stock fund in the issuer's 401(K) Plan as of December 28, 2018. This amendment is being filed to include these shares of the issuer's common stock that were omitted in the prior report.